Clinical Trial Update: The Efficacy and Safety of Temozolomide in Patients With MPPGL [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating temozolomide for malignant pheochromocytoma and paraganglioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paraganglioma
• Paraganglioma Malignant
• Pheochromocytoma
• Pheochromocytoma Malignant
• Pheochromocytoma Metastatic

Drugs mentioned

• Temozolomide (Temozolomide)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Pheochromocytoma, Metastatic, Paraganglioma, Malignant | Phase 2 | Status: COMPLETED